I think that the point is that we don't know how close the company is to EDEN approval. Even the company may only be able to guess as they are not in control, the regulators are.
Certainly they know more than we do, but they really can't talk as the regulators frown on such discussion where they are involved.
Hopefully with approval we can get a very general feel for the status of other things, but you can bet it will be light and on specifics
I just spoke with a friend of mine. He asked his friend within our group, an NWBO shareholder with a tremendous big holding, why they are printing shares as insanely, as you have rightfully complained about. The answer was they are printing so many shares for one reason and one reason only: the increase of Advent capacity and Advent preparation for: the MHRA decision, the (in the last 10Q) announced joint trial and direct startup. Thats it really.
Market Data 
Markets 
AI
